1663 completed, 286 unknown, 176 terminated, 88 withdrawn. 481 Phase 2, 392 Phase 3, 339 Phase 1, 302 Not applicable, 294 Phase 4.
Follow Hepatitis C: new trials by email Literature Review of Hepatitis C trials Research Report on Hepatitis C
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans Integrated care - Opioid Use Disorder, HIV | Not applicable | Not yet recruiting | VA Office of Research and Development | 60 | 2028-04-03 | 2026-04-24 |
| STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR) - HIV, Substance Use Disorder (SUD) | Not applicable | Not yet recruiting | University of Miami | 200 | 2027-05-01 | 2026-11-12 |
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-11-09 |
| A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) AVIHepC1, Normal Saline - Hepatitis C | Phase 1 | Not yet recruiting | University of Alberta | 27 | 2027-01-15 | 2026-09-25 |
| AI-Powered Hepatitis C Single-Encounter Test-and-Treat Epclusa (sofosbuvir and velpatasvir) - HEPATITIS C (HCV) | Phase 4 | Not yet recruiting | Patrick Grace | 35 | 2026-12-01 | 2026-08-28 |
| ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid) - Hepatitis C | Not applicable | Not yet recruiting | Johns Hopkins University | 200 | 2026-11-01 | 2025-11-10 |
| Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived Use INSTI HCV Antibody Test - HCV Infection | Not applicable | Not yet recruiting | bioLytical Laboratories | 388 | 2026-11-01 | 2026-10-29 |
| Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection INSTI HCV Antibody Test - HCV Infection | Not applicable | Not yet recruiting | bioLytical Laboratories | 1660 | 2026-11-01 | 2026-10-29 |
| Treatment of CKD Patients With HCV SOF+DCV, OBV/PTV/r) ± ribavirin (RBV) - HCV Infection ( Genotype 4) in CKD Patients | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 50 | 2026-09-15 | 2026-08-20 |
| Strengthening, Guidance, Health, Empowerment Self-sampling for six sexually transmitted infections - HIV Infection, Syphilis | Not applicable | Not yet recruiting | University Hospital, Montpellier | 200 | 2026-09-01 | 2026-08-26 |
| Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs Partner navigation intervention booster session - HEPATITIS C (HCV), Opioid Use Disorder | Not applicable | Not yet recruiting | University of California, San Francisco | 50 | 2026-09-01 | 2026-06-08 |
| Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3) Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID) - HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV) | Not applicable | Not yet recruiting | University of Georgia | 50 | 2026-08-01 | 2025-12-18 |
| Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System Physician-Initiated Screening (Conventional Screening), FOCUS (Universal Screening), HepC-EnD (Targeted Screening) - Hepatitis C Virus (HCV), Hepatitis C Virus (HCV) Infection | Not yet recruiting | University of Florida | 6466 | 2026-07-01 | 2026-04-29 | |
| Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV Glecaprevir/pibrentasvir - Hepatitis C | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2026-06-25 | 2026-08-14 |
| Genotype and Subtype Mapping of the Hepatitis C Virus Hepatitis C Virus, Mutation Abnormality | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 2500 | 2026-06-01 | 2026-05-19 | |
| Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing PPP-CCM - HEPATITIS C (HCV) | Not applicable | Recruiting | University of Washington | 444 | 2026-06-01 | 2026-11-12 |
| MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo MAGIA H3S - HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus) | Not yet recruiting | Gardiens de Vies | 7500 | 2026-03-01 | 2026-02-05 | |
| Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data Hepatitis C Virus (HCV) | Recruiting | AbbVie | 2000 | 2026-02-27 | 2026-04-16 | |
| Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer PIVKA-II and GAAD score calculation - Liver Cirrhosis, Hepatitis B, Chronic | Not applicable | Enrolling by invitation | Siriraj Hospital | 2100 | 2026-02-02 | 2026-04-24 |
| "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" Blood sampling, Umbilical cord blood sampling, Survey using a questionnaire - HIV Infection, HBV Infection | Not yet recruiting | ANRS, Emerging Infectious Diseases | 5160 | 2026-02-01 | 2026-02-17 |
Showing 20 of 2311. Sign in to see all of them.
Hepatitis C, Chronic (907) · HIV Infections (128) · Hepatitis B (106) · Fibrosis (102) · Acquired Immunodeficiency Syndrome (92) · Hepatitis (86) · Liver Diseases (74) · Liver Cirrhosis (67) · Carcinoma, Hepatocellular (58) · Substance-Related Disorders (36) · Virus Diseases (33) · Hepatitis, Chronic (31) · Opioid-Related Disorders (28) · Infections (24)
Blood-Borne Infections (2311) · Flaviviridae Infections (2300) · Communicable Diseases (2298) · Digestive System Diseases (2298) · RNA Virus Infections (2296) · Hepatitis, Viral, Human (2292) · Infections (2287) · Virus Diseases (2278) · Liver Diseases (2237) · Hepatitis (2225) · Pathological Conditions, Signs and Symptoms (1100) · Pathologic Processes (1090) · Disease Attributes (978) · Chronic Disease (948) · Hepatitis, Chronic (897)
Ribavirin (654) · peginterferon alfa-2a (306) · Sofosbuvir (173) · peginterferon alfa-2b (155) · daclatasvir (99) · sofosbuvir-velpatasvir drug combination (79) · Simeprevir (72) · telaprevir (71) · ledipasvir, sofosbuvir drug combination (68) · paritaprevir (61) · ombitasvir (59) · Ritonavir (56) · dasabuvir (54) · grazoprevir (50) · glecaprevir and pibrentasvir (49)
Merck Sharp & Dohme LLC (163) · Gilead Sciences (119) · AbbVie (91) · Bristol-Myers Squibb (91) · Hoffmann-La Roche (88) · National Institute of Allergy and Infectious Diseases (NIAID) (38) · Kirby Institute (32) · National Taiwan University Hospital (32) · ANRS, Emerging Infectious Diseases (31) · Tibotec Pharmaceuticals, Ireland (29) · Boehringer Ingelheim (28) · Vertex Pharmaceuticals Incorporated (28) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (26) · Assiut University (22) · GlaxoSmithKline (18)
United States (856) · France (245) · Canada (189) · Germany (188) · Spain (170) · Puerto Rico (161) · United Kingdom (144) · Australia (143) · Italy (108) · Belgium (101) · Taiwan (95) · Egypt (93) · New Zealand (82) · Poland (80) · Japan (68)
Chen-Hua Liu, MD (16)
PMID 30739368, PMID 30977945, PMID 30012435, PMID 30923816, PMID 28193518, PMID 29461687, PMID 31568620, PMID 30529905, PMID 29377566, PMID 29404492, PMID 25445400, PMID 30868245, PMID 23607594, PMID 24209977, PMID 25040192, PMID 25583164, PMID 26575258, PMID 26683763, PMID 27847279, PMID 35174470, PMID 37096802, PMID 22821361, PMID 23607593, PMID 24329937, PMID 26743093, PMID 26947564, PMID 27553375, PMID 36740893, PMID 12823087, PMID 16122679, PMID 17552026, PMID 18054553, PMID 20130466, PMID 20189674, PMID 20199501, PMID 20951424, PMID 21488067, PMID 21688284, PMID 22239511, PMID 22335782, PMID 22626609, PMID 22994906, PMID 23239552, PMID 23300053, PMID 23747481, PMID 24126097, PMID 24154738, PMID 24428467, PMID 24720702, PMID 24983020
2015 (35), 2014 (34), 2009 (20), 2016 (17), 2008 (10), 2004 (7), 2005 (7), 2017 (3), 2018 (3), U01DK062498 (3), UL1TR001082 (3), UM1AI068636 (3), 2019 (2), P30AI042853 (2), R01DA013806 (2)